EORTC abstracts selected at ESMO 2019
18 Sep 2019
In total, EORTC will be presenting 3 abstracts (2 oral presentations and 1 poster) at the ESMO Congress 2019 from 27 September until 1 October in Barcelona, Spain.
Andrew Bottomley, Head of the Quality of Life at EORTC, will chair a session about “Surviving a cancer diagnosis with a good QoL” on 30 September from 8:30 to 10:00 and give a lecture on “Can value frameworks (such as ESMO-MCBS) contribute to a higher QoL?”
During the same session, Madeline Pe, EORTC Specialist in QoL, will talk about EORTC’s work on survivorship.
Meet us at our booth located in the society village n°20.
Oral presentations
A phase II study of Monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R Galot, C Le Tourneau, E Saada-Bouzid, A Daste, C Even, P Debruyne, S Henry, S Zanetta, A Rutten, L Licitra, JL Canon, MC Kaminsky, P Specenier, S Rottey, L Dirix, T Raveloarivahy, C Fortpied, M Vanlancker, A Govaerts, JP Machiels
Presentation number: 1109O
Speaker: Rachel Galot
Date: 30.09.2019 – Lecture time: 10:15 – 11:45 – Location: Cordoba Auditorium (Hall 7)
Redefining the IGCCCG Classification in advanced Non-Seminoma
Gillessen S, Collette L, Daugaard G, De Wit R, Tryakin A, Albany C, Stahl O, Fizazi K, Gietema J, De Giorgi U, Hansen AR, Feldman D, Cafferty FH, Tandstad T, Garcia del Muro X, Huddart R, Sweeney C, Heng DY, Sauvé N and Beyer J for the IGCCCG Update Consortium
Presentation number: 903O
Speaker: Silke Gillessen
Date: 28.09.2019 – Lecture time: 15:30 – 15:45 – Location: Sevilla Auditorium (Hall 2)
Poster
There is a lack of clinical research for patients with cancer in palliative care
M. Vinches, A. Neven, L. Fenwarth, M. Terada, G. Rossi, S. Kelly, J. Peron, M. Thomaso, M. Groenvold, T. De Rojas
Poster number: 1610P
Poster presenter: Marie Vinches
Date: 28.09.2019 – Lecture time: 12:20 – Location: Poster Area (Hall 4)
Related News
Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value
23 Apr 2026
In Memoriam of Martine Van Glabbeke (1951-2026)
17 Apr 2026
PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases
27 Feb 2026
EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers
27 Feb 2026
First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma
26 Feb 2026
World Cancer Day: How clinical cancer research changes lives
4 Feb 2026
New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events
27 Jan 2026
First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG
26 Jan 2026
EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology
16 Jan 2026
New EORTC quality of life questionnaire for adolescents and young adults with cancer
8 Jan 2026
